• Home
  •  / BGI Genomics

BGI Genomics

OverviewSuggest Edit

BGI Genomics (华大基因) is a company offering genomic sequencing and proteomic services. It engages in DNA and RNA sequencing, hereditary cancer screening, non-invasive prenatal screening, etc. The company also provides mass spectrometry, pharma, and COVID-19 solutions. BGI Genomics caters to academic institutions, pharmaceutical companies, health care providers, and other organizations.
TypePublic
Founded1999
HQShenzhen Shi, CNMap
Websitebgi.com
View Jobs (1,342)

Recent NewsAll News

Latest Updates

Employees (est.) (May 2021)3,778(+6%)
Job Openings1,342
Revenue (FY, 2019)¥2.8 B(+11%)
Share Price (Sept 2021)¥92
Cybersecurity ratingDMore

Key People/Management at BGI Genomics

Du Yutao

Du Yutao

Deputy General Manager, Director
Liu Na

Liu Na

Deputy General Manager
Chen Yiqing

Chen Yiqing

Financial Director
Li Zhiping

Li Zhiping

Director of Human Resources
Yin Ye

Yin Ye

Vice Chairman of the Board,bgi Genomics Co,. Ltd.
Wang Jian

Wang Jian

Chairman of the Board
Show more

BGI Genomics Office Locations

BGI Genomics has offices in Shenzhen Shi, Cambridge, København, Hong Kong and in 1 other location
Shenzhen Shi, CN (HQ)
21 Hong'an 3rd St, Yantian Qu
København, DK
Ole Maaløes Vej 3
Hong Kong, HK
16 Dai Fu St, Tai Po Industrial Estate
Kobe, JP
2-chōme-2-2 Minatojima Minamimachi, Chuo Ward
Cambridge, MA, US
One Broadway, 3rd Floor
Show all (5)

BGI Genomics Financials and Metrics

BGI Genomics Revenue

BGI Genomics's revenue was reported to be ¥2.8 b in FY, 2019 which is a 10.4% increase from the previous period.
CNY

Revenue (H1, 2020)

4.1b

Net income (H1, 2020)

1.7b

EBIT (H1, 2020)

2.0b

Market capitalization (17-Sept-2021)

38.1b

Closing stock price (17-Sept-2021)

92.0

Cash (30-Jun-2020)

3.1b

EV

35.9b
BGI Genomics's current market capitalization is ¥38.1 b.
Annual
CNYFY, 2017FY, 2018FY, 2019

Revenue

2.1b2.5b2.8b

Revenue growth, %

21%10%

Sales and marketing expense

401.9m514.3m618.7m

General and administrative expense

327.8m166.3m197.5m
Half Year
CNYH1, 2018H1, 2019H1, 2020

Revenue

1.1b1.3b4.1b

Sales and marketing expense

201.3m267.4m326.4m

General and administrative expense

166.9m70.5m154.8m

R&D expense

143.0m167.0m
show all
Annual
CNYFY, 2017FY, 2018FY, 2019

Cash

946.6m1.1b735.3m

Accounts Receivable

811.6m1.3b1.2b

Prepaid Expenses

47.4m79.1m224.8m

Inventories

138.6m241.9m343.0m
Half Year
CNYH1, 2018H1, 2019H1, 2020

Cash

1.4b856.0m3.1b

Accounts Receivable

1.1b1.3b1.5b

Prepaid Expenses

103.7m253.7m511.5m

Inventories

178.4m287.2m1.3b
show all
Annual
CNYFY, 2017FY, 2018FY, 2019

Net Income

423.7m407.8m278.5m

Accounts Payable

(761.6m)(1.1b)(1.2b)

Cash From Operating Activities

226.6m14.7m224.3m

Cash From Investing Activities

(392.8m)502.0m(842.7m)
Half Year
CNYH1, 2018H1, 2019H1, 2020

Net Income

215.2m197.9m1.7b

Accounts Payable

(482.7m)(598.0m)(1.9b)

Cash From Operating Activities

(79.0m)(122.8m)2.0b

Cash From Investing Activities

419.8m(48.9m)(359.6m)
show all
CNYFY, 2017

Financial Leverage

1.2 x
Show all financial metrics

BGI Genomics Operating Metrics

BGI Genomics's Customers was reported to be 480 k in FY, 2019.
FY, 2017H1, 2018FY, 2018H1, 2019FY, 2019H1, 2020

Countries

100100100100100100

Customers (Hospitals, China)

160200231

Customers

480 k

Medical Institutions Covered (China)

2.3 k2.3 k2.3 k
Show all operating metrics

BGI Genomics Acquisitions / Subsidiaries

Company NameDateDeal Size
Beijing Huada Medical Laboratory Co Ltd
Beijing Huada Unicom Technology Limited company
Benxi Huada Medical Laboratory Co Ltd
BGI Europe A/S
BGI HEALTH (HK) CO LTD
Guangzhou BGI Gene Medicine Inspection Institute Co Ltd
Hebei Huada Medical Laboratory Laboratories Ltd
Huada Biotechnology (Wu Chinese) Co Ltd
Huada Shuji Biotechnology (Shenzhen) Co Ltd
Nanjing BGI Gene Technology Limited company
Show more

BGI Genomics Revenue Breakdown

Embed Graph

BGI Genomics revenue breakdown by business segment: 42.0% from Reproductive health research and clinical application services, 20.4% from Solutions for precision medical testing, 24.3% from Multi-omic big data service, 10.1% from Tumor prevention and transplanting services and 3.1% from Other

BGI Genomics revenue breakdown by geographic segment: 83.4% from Mainland China, 6.9% from Europe, Africa and Middle East, 5.1% from Asia (excluding Mainland China) and 4.5% from Other

BGI Genomics Cybersecurity Score

Cybersecurity ratingPremium dataset

D

61/100

Learn more about our premium products
SecurityScorecard logo

BGI Genomics Online and Social Media Presence

BGI Genomics's Trends

Embed Graph

BGI Genomics News and Updates

March 17, 2021

DNA Sequencing Market to Grow by USD 17.92 Billion during 2021-2025|Agilent Technologies Inc. and BGI Genomics Co. Ltd. Emerge as Key Contributors |Technavio

NEW YORK, March 17, 2021 /PRNewswire/ -- The global DNA sequencing market is expected to grow by USD 17.92 billion during 2021-2025, as per Technavio. This marks a significant market slow down compared to the 2020 growth estimates due to the impact of the COVID-19 pandemic in the first...

 BGI Genomics Frequently Asked Questions

  • When was BGI Genomics founded?

    BGI Genomics was founded in 1999.

  • Who are BGI Genomics key executives?

    BGI Genomics's key executives are Du Yutao, Liu Na and Chen Yiqing.

  • How many employees does BGI Genomics have?

    BGI Genomics has 3,778 employees.

  • What is BGI Genomics revenue?

    Latest BGI Genomics annual revenue is ¥2.8 b.

  • What is BGI Genomics revenue per employee?

    Latest BGI Genomics revenue per employee is ¥741.2 k.

  • Who are BGI Genomics competitors?

    Competitors of BGI Genomics include ZAI Lab, Eurofins and Illumina.

  • Where is BGI Genomics headquarters?

    BGI Genomics headquarters is located at 21 Hong'an 3rd St, Yantian Qu, Shenzhen Shi.

  • Where are BGI Genomics offices?

    BGI Genomics has offices in Shenzhen Shi, Cambridge, København, Hong Kong and in 1 other location.

  • How many offices does BGI Genomics have?

    BGI Genomics has 5 offices.